Which test to use to measure the anticoagulant effect of rivaroxaban: the anti-factor Xa assay

Evaluation of the Prothrombin Time for Measuring Rivaroxaban Plasma Concentrations Using Calibrators and Controls

(2012) Meyer Michel Samama et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Accurate determination of rivaroxaban levels requires different calibrator sets but not addition of antithrombin

(2012) Gabriele Rohde et al.   THROMBOSIS AND HAEMOSTASIS

Do new oral anticoagulants require laboratory monitoring? The clinician point of view

(2012) Meyer Michel Samama et al.   THROMBOSIS RESEARCH

Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxaban

(2011) Job Harenberg et al.   BLOOD COAGULATION & FIBRINOLYSIS

Laboratory assessment of new anticoagulants

(2011) Meyer M. Samama et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls

(2011) Genevieve Contant et al.   THROMBOSIS AND HAEMOSTASIS

The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study

(2010) A. TRIPODI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Assays for Measuring Rivaroxaban: Their Suitability and Limitations

(2010) Edelgard Lindhoff-Last et al.   THERAPEUTIC DRUG MONITORING

An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma

(2010) Jean Amiral et al.   THROMBOSIS AND HAEMOSTASIS

Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay

(2010) Zhaoqing Wang et al.   THROMBOSIS AND HAEMOSTASIS